Russell Williams

Federal parties’ long-term support vital to tackle frailty among older Canadians

• They are the silent one million. Though unrecognized as a distinct group in our health care matrix, a large, increasing portion of Canada’s population

Opinion | BY RUSSELL WILLIAMS, DR. JOHN MUSCEDERE | May 16, 2019

Federal parties’ long-term support vital to tackle frailty among older Canadians

Opinion | BY RUSSELL WILLIAMS, DR. JOHN MUSCEDERE | May 16, 2019

• They are the silent one million. Though unrecognized as a distinct group in our health care matrix, a large, increasing portion of Canada’s population

Federal parties’ long-term support vital to tackle frailty among older Canadians

Opinion | BY RUSSELL WILLIAMS, DR. JOHN MUSCEDERE | May 16, 2019

• They are the silent one million. Though unrecognized as a distinct group in our health care matrix, a large, increasing portion of Canada’s population

Federal parties’ long-term support vital to tackle frailty among older Canadians

• They are the silent one million. Though unrecognized as a distinct group in our health care matrix, a large, increasing portion of Canada’s population

Opinion | BY RUSSELL WILLIAMS, DR. JOHN MUSCEDERE | May 16, 2019

Federal parties’ long-term support vital to tackle frailty among older Canadians

Opinion | BY RUSSELL WILLIAMS, DR. JOHN MUSCEDERE | May 16, 2019

• They are the silent one million. Though unrecognized as a distinct group in our health care matrix, a large, increasing portion of Canada’s population

Federal parties’ long-term support vital to tackle frailty among older Canadians

Opinion | BY RUSSELL WILLIAMS, DR. JOHN MUSCEDERE | May 16, 2019

• They are the silent one million. Though unrecognized as a distinct group in our health care matrix, a large, increasing portion of Canada’s population

Consider the value of pharmaceutical medicines

•   Too often, the public debate about pharmaceutical medicines revolves around the bottom line.  There is no question that cost is important, but this

News | BY RUSSELL WILLIAMS | December 1, 2012

Consider the value of pharmaceutical medicines

News | BY RUSSELL WILLIAMS | December 1, 2012

•   Too often, the public debate about pharmaceutical medicines revolves around the bottom line.  There is no question that cost is important, but this

Consider the value of pharmaceutical medicines

News | BY RUSSELL WILLIAMS | December 1, 2012

•   Too often, the public debate about pharmaceutical medicines revolves around the bottom line.  There is no question that cost is important, but this

Canada’s access to medicines regime: not a panacea to developing world

• We as Canadians should be proud that Canada was one of the first countries to enact legislation that responds to the developing world’s need

News | BY RUSSELL WILLIAMS | April 27, 2009

Canada’s access to medicines regime: not a panacea to developing world

News | BY RUSSELL WILLIAMS | April 27, 2009

• We as Canadians should be proud that Canada was one of the first countries to enact legislation that responds to the developing world’s need

Canada’s access to medicines regime: not a panacea to developing world

News | BY RUSSELL WILLIAMS | April 27, 2009

• We as Canadians should be proud that Canada was one of the first countries to enact legislation that responds to the developing world’s need

More Stories